Can an online program help teens stop self-harm? new study tests internet therapy
NCT ID NCT06817278
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests an internet-delivered therapy (IERITA) for teens aged 13-17 who engage in nonsuicidal self-injury. The 12-week program teaches emotion regulation skills through online modules, videos, and therapist messaging. Researchers will check if the approach is feasible and acceptable before planning a larger trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Internet-delivered emotion regulation therapy (IERITA)
What this could lead to
If successful, this could provide a scalable online treatment option for teens who self-injure, reducing the need for in-person visits.
What could go wrong
This is a small pilot study focused on feasibility, not effectiveness. The therapy may not work for everyone, and results may not apply to all teens.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SELF HARM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska Institutet
Stockholm, 113 64, Sweden